160 related articles for article (PubMed ID: 21356088)
1. A spatial approach for the epidemiology of antibiotic use and resistance in community-based studies: the emergence of urban clusters of Escherichia coli quinolone resistance in Sao Paulo, Brasil.
Kiffer CR; Camargo EC; Shimakura SE; Ribeiro PJ; Bailey TC; Pignatari AC; Monteiro AM
Int J Health Geogr; 2011 Feb; 10():17. PubMed ID: 21356088
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with ciprofloxacin- and cefotaxime-resistant Escherichia coli in women with acute pyelonephritis in the emergency department.
Park KH; Oh WS; Kim ES; Park SW; Hur JA; Kim YK; Moon C; Lee JH; Lee CS; Kim BN
Int J Infect Dis; 2014 Jun; 23():8-13. PubMed ID: 24657271
[TBL] [Abstract][Full Text] [Related]
3. Urinary Tract Physiological Conditions Promote Ciprofloxacin Resistance in Low-Level-Quinolone-Resistant Escherichia coli.
Martín-Gutiérrez G; Rodríguez-Beltrán J; Rodríguez-Martínez JM; Costas C; Aznar J; Pascual Á; Blázquez J
Antimicrob Agents Chemother; 2016 Jul; 60(7):4252-8. PubMed ID: 27139482
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin resistance in uropathogenic Escherichia coli isolates causing community-acquired urinary infections in Brasília, Brazil.
Moreira da Silva RCR; de Oliveira Martins Júnior P; Gonçalves LF; de Paulo Martins V; de Melo ABF; Pitondo-Silva A; de Campos TA
J Glob Antimicrob Resist; 2017 Jun; 9():61-67. PubMed ID: 28419868
[TBL] [Abstract][Full Text] [Related]
5. Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting.
Gottesman BS; Carmeli Y; Shitrit P; Chowers M
Clin Infect Dis; 2009 Sep; 49(6):869-75. PubMed ID: 19686074
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland.
Nicoletti J; Kuster SP; Sulser T; Zbinden R; Ruef C; Ledergerber B; Weber R
Swiss Med Wkly; 2010; 140():w13059. PubMed ID: 20648400
[TBL] [Abstract][Full Text] [Related]
7. Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital.
Gallini A; Degris E; Desplas M; Bourrel R; Archambaud M; Montastruc JL; Lapeyre-Mestre M; Sommet A
J Antimicrob Chemother; 2010 Dec; 65(12):2650-7. PubMed ID: 20876240
[TBL] [Abstract][Full Text] [Related]
8. Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment.
Zaytoun OM; Vargo EH; Rajan R; Berglund R; Gordon S; Jones JS
Urology; 2011 May; 77(5):1035-41. PubMed ID: 21420152
[TBL] [Abstract][Full Text] [Related]
9. Association between urinary community-acquired fluoroquinolone-resistant Escherichia coli and neighbourhood antibiotic consumption: a population-based case-control study.
Low M; Neuberger A; Hooton TM; Green MS; Raz R; Balicer RD; Almog R
Lancet Infect Dis; 2019 Apr; 19(4):419-428. PubMed ID: 30846277
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic Resistance of Bacteria Involved in Urinary Infections in Brazil: A Cross-Sectional and Retrospective Study.
Rodrigues WF; Miguel CB; Nogueira AP; Ueira-Vieira C; Paulino Tde P; Soares Sde C; De Resende EA; Lazo-Chica JE; Araújo MC; Oliveira CJ
Int J Environ Res Public Health; 2016 Sep; 13(9):. PubMed ID: 27649224
[TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolone Use and Seasonal Patterns of Ciprofloxacin Resistance in Community-Acquired Urinary Escherichia coli Infection in a Large Urban Center.
Soucy JR; Schmidt AM; Quach C; Buckeridge DL
Am J Epidemiol; 2020 Mar; 189(3):215-223. PubMed ID: 31665215
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
13. Excess body weight and age associated with the carriage of fluoroquinolone and third-generation cephalosporin resistance genes in commensal Escherichia coli from a cohort of urban Vietnamese children.
Thi Quynh Nhi L; Thanh Tuyen H; Duc Trung P; Do Hoang Nhu T; Duy PT; Hao CT; Thi Thanh Nhan N; Vi LL; Thi Diem Tuyet H; Thi Thuy Tien T; Van Vinh Chau N; Khanh Lam P; Thwaites G; Baker S
J Med Microbiol; 2018 Oct; 67(10):1457-1466. PubMed ID: 30113307
[TBL] [Abstract][Full Text] [Related]
14. Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection.
Allou N; Cambau E; Massias L; Chau F; Fantin B
Antimicrob Agents Chemother; 2009 Oct; 53(10):4292-7. PubMed ID: 19635960
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark.
Cavaco LM; Frimodt-Møller N; Hasman H; Guardabassi L; Nielsen L; Aarestrup FM
Microb Drug Resist; 2008 Jun; 14(2):163-9. PubMed ID: 18500921
[TBL] [Abstract][Full Text] [Related]
16. Soft sweep development of resistance in Escherichia coli under fluoroquinolone stress.
Xie X; Lv R; Yang C; Song Y; Yan Y; Cui Y; Yang R
J Microbiol; 2019 Dec; 57(12):1056-1064. PubMed ID: 31555989
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of ciprofloxacin resistance and clonal relatedness of clinical Escherichia coli isolates from haematology patients receiving ciprofloxacin prophylaxis.
van Hees BC; Tersmette M; Willems RJ; de Jong B; Biesma D; van Hannen EJ
J Antimicrob Chemother; 2011 Aug; 66(8):1739-44. PubMed ID: 21636586
[TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.
Karlowsky JA; Hoban DJ; Decorby MR; Laing NM; Zhanel GG
Antimicrob Agents Chemother; 2006 Jun; 50(6):2251-4. PubMed ID: 16723598
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
[TBL] [Abstract][Full Text] [Related]
20. Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model.
Vellinga A; Tansey S; Hanahoe B; Bennett K; Murphy AW; Cormican M
J Antimicrob Chemother; 2012 Oct; 67(10):2523-30. PubMed ID: 22729920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
